Jonathan Richman

Healthcare technologist and founder of Dose.

My name is Jonathan Richman (not the singer) and my day job is as a marketing consultant at the agency I founded, Dose, which specializes in digital marketing for the healthcare industry.

My previous job was as Vice President, Product Marketing for Cincinnati-based startup Zipscene, an integrated digital marketing platform for the restaurant industry. I was responsible for leading product development and all marketing and thought leadership efforts for Zipscene.

Prior to joining Zipscene, I was group director of Insights and Planning at Possible Worldwide Cincinnati (formerly Bridge Worldwide) for nearly five years and was responsible for providing strategic direction and leadership for its clients.

I was the creator and author of popular industry blog Dose of Digital, which provides insights on digital marketing in the health industry. AdAge Power 150 named it one of the top overall marketing blogs. You can read all my past posts here.

I'm a regular speaker at major national marketing conventions and have been quoted in publications including The Wall Street Journal and The Washington Post. I was invited by the Food and Drug Administration to speak at its public hearings on social media in pharmaceuticals and have been interviewed on NPR's "All Things Considered."

Beyond health care, I'm a contributor for digital marketing journals such as iMedia Connection and AdAge's DigitalNext, where I've contributed articles on all manner of digital marketing topics. I was also named as a winner of a WPP Atticus award, which recognizes the best thought leadership within WPP for "WeHateYour.com." Check out the video on this page or visit the full site.

Prior to joining Possible Worldwide in 2007, I worked at AstraZeneca Pharmaceuticals for more than 11 years, holding positions in sales, training, sales leadership and marketing. In my last role, I was U.S. Brand Leader for Faslodex, a company that produces specialty injectable treatment for advanced breast cancer.